- Home
- MLYS vs BFST Comparison
MLYS vs BFST Comparison
Compare MLYS & BFST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLYS
- BFST
- Stock Information
- Founded
- MLYS 2019
- BFST 2006
- Country
- MLYS United States
- BFST United States
- Employees
- MLYS N/A
- BFST N/A
- Industry
- MLYS Biotechnology: Pharmaceutical Preparations
- BFST Major Banks
- Sector
- MLYS Health Care
- BFST Finance
- Exchange
- MLYS Nasdaq
- BFST Nasdaq
- Market Cap
- MLYS 890.6M
- BFST 783.9M
- IPO Year
- MLYS 2023
- BFST 2018
- Fundamental
- Price
- MLYS $14.89
- BFST $25.42
- Analyst Decision
- MLYS Strong Buy
- BFST Strong Buy
- Analyst Count
- MLYS 4
- BFST 3
- Target Price
- MLYS $27.00
- BFST $30.00
- AVG Volume (30 Days)
- MLYS 869.6K
- BFST 97.4K
- Earning Date
- MLYS 08-12-2025
- BFST 07-28-2025
- Dividend Yield
- MLYS N/A
- BFST 2.32%
- EPS Growth
- MLYS N/A
- BFST 3.92
- EPS
- MLYS N/A
- BFST 2.51
- Revenue
- MLYS N/A
- BFST $291,096,000.00
- Revenue This Year
- MLYS N/A
- BFST $25.48
- Revenue Next Year
- MLYS N/A
- BFST $17.20
- P/E Ratio
- MLYS N/A
- BFST $9.59
- Revenue Growth
- MLYS N/A
- BFST 17.48
- 52 Week Low
- MLYS $8.24
- BFST $20.07
- 52 Week High
- MLYS $18.38
- BFST $30.30
- Technical
- Relative Strength Index (RSI)
- MLYS 55.68
- BFST 61.95
- Support Level
- MLYS $14.26
- BFST $23.66
- Resistance Level
- MLYS $15.55
- BFST $24.11
- Average True Range (ATR)
- MLYS 0.85
- BFST 0.53
- MACD
- MLYS 0.18
- BFST 0.17
- Stochastic Oscillator
- MLYS 77.53
- BFST 98.59
About MLYS Mineralys Therapeutics Inc.
Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.
About BFST Business First Bancshares Inc.
Business First Bancshares Inc is a bank holding company. The company's services include personal and commercial banking, treasury management, and wealth solutions. It provides a range of financial services to small-to-midsized businesses and professionals. The company generates majority of its revenues from interest income on loans, customer service and loan fees, and interest income from securities.